Skip to content
  • About Us
  • Our Science
  • Clinical Programs
  • News
  • Publications
  • Contact Us
  • About Us
  • Our Science
  • Clinical Programs
  • News
  • Publications
  • Contact Us

Board

Kris Vinckier

Board / Susan Serrao

Board Member

Kris Vinckier Read More »

Kerry Maguire, DDS, MSPH

Board / Susan Serrao

Board Member

Kerry Maguire, DDS, MSPH Read More »

Valerie Ceva, MBA

Board, Leadership / serrao6

Chief Operating Officer
Board Member

Valerie Ceva, MBA Read More »

Susan L. Levinson, PhD.

Board, Leadership / serrao6

Chief Executive Officer
Board Member

Susan L. Levinson, PhD. Read More »

Recent News

August 20, 2025: BioAegis Therapeutics Awarded Second FDA Fast Track Designation for Recombinant Human Gelsolin to Treat Inflammasome-Driven Decompression Sickness (DCS)

August 20, 2025
Read More »

June 17, 2025: BioAegis Therapeutics Receives FDA Fast Track Designation for Lead Product, Recombinant Human Gelsolin, for the Treatment of Acute Respiratory Distress Syndrome (ARDS)

June 17, 2025
Read More »

Company Location

NJ Bioscience Center
685 US Route 1
North Brunswick, NJ 08902

Follow Us

Twitter Linkedin Youtube

©2025 BioAegis® Therapeutics Inc.
Careers | Privacy Policy | Code of Business Conduct and Ethics | Terms of Use